Effects of Rituximab Treatment on the Serum Concentrations of Vitamin D and Interleukins 2, 6, 7, and 10 in Patients with Rheumatoid Arthritis

Overview

Journal Biologics

Date 2012 Feb 23

PMID 22355257

Citations 7

Authors

Eman Hasan

Samuel Olusi

Adel Al-Awadhi

Khalid Mokaddem

Prem Sharma

Sunila George

Affiliations

Soon will be listed here.

Abstract

Background: Rituximab, a monoclonal antibody that selectively targets CD20-positive B-lymphocytes, is used for the treatment of patients with rheumatoid arthritis (RA) with an inadequate response or tolerance to tumor necrosis factor inhibitors. The objective of this study was to investigate the effects of rituximab treatment on the serum concentrations of vitamin D, interleukin (IL) 2, IL-6, IL-7, and IL-10 in patients with rheumatoid arthritis (RA).

Methods: Forty-five patients, aged 25-78 years, were enrolled into a cohort prospective study. All patients were treated with intravenous rituximab. Disease activity score-28 (DAS-28) and serum concentrations of rheumatoid factor (RF), C-reactive protein (CRP), anticyclic citrullinated peptide (anti-CCP), erythrocyte sedimentation rate (ESR), health assessment questionnaire (HAQ), vitamin D, ILs 2, 6, 7, and 10 were estimated in the patients before and after treatment with rituximab.

Results: DAS-28, HAQ score, and serum concentrations of CRP, RF, anti-CCP, IL-2, IL-6, IL-7, IL-10, and ESR significantly decreased after treatment. All 45 patients had vitamin D deficiency before treatment and this did not significantly change after treatment. However no significant association was found among serum vitamin D concentration and any of the ILs.

Conclusion: We concluded from this study that although rituximab treatment of patients with RA significantly reduced their disease activity and serum concentrations of IL-2, IL-6, IL-7, and IL-10, it did not significantly alter their vitamin D status. Furthermore, no significant association was found among serum vitamin D concentration and any of the ILs.

Citing Articles

Comparison of the Clinical Efficacy of Rituximab Infusion and Dexamethasone-Cyclophosphamide Pulse Therapy and Their Effect on Serum Th1, Th2, and Th17 Cytokines in Pemphigus Vulgaris-A Prospective, Nonrandomized, Comparative Pilot Study.

Khandpur S, Sharma P, Sharma V, Das D, Sharma A, Bhari N Indian Dermatol Online J. 2024; 15(3):464-472.

PMID: 38845632 PMC: 11152478. DOI: 10.4103/idoj.idoj_558_23.

Unexpected Positive Effects of Rituximab and Corticosteroids on COVID-19 in a Patient Suffering from Granulomatosis with Polyangiitis.

Salesi M, Shojaie B, Naderi Z Adv Biomed Res. 2021; 10:25.

PMID: 34760807 PMC: 8531733. DOI: 10.4103/abr.abr_266_20.

Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.

Madanchi N, Bitzan M, Takano T Can J Kidney Health Dis. 2017; 4:2054358117698667.

PMID: 28540057 PMC: 5433659. DOI: 10.1177/2054358117698667.

Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy.

Bruzzese V, Zullo A, Picchianti Diamanti A, Ridola L, Lorenzetti R, Marrese C Intern Emerg Med. 2016; 11(6):803-7.

PMID: 26939587 DOI: 10.1007/s11739-016-1415-9.

Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis.

Lin J, Liu J, Davies M, Chen W PLoS One. 2016; 11(1):e0146351.

PMID: 26751969 PMC: 4709104. DOI: 10.1371/journal.pone.0146351.

References

Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D . Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007; 56(7):2143-9. DOI: 10.1002/art.22722. View

Arnson Y, Amital H, Shoenfeld Y . Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007; 66(9):1137-42. PMC: 1955167. DOI: 10.1136/ard.2007.069831. View

Costenbader K, Feskanich D, Holmes M, Karlson E, Benito-Garcia E . Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis. 2007; 67(4):530-5. PMC: 2717608. DOI: 10.1136/ard.2007.072736. View

Anderson L, Cotterchio M, Vieth R, Knight J . Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr. 2010; 91(6):1699-707. DOI: 10.3945/ajcn.2009.28869. View

Shehab D, Al-Jarallah K, Moussa M . Validation of the Arabic version of the Health Assessment Questionnaire (HAQ) in patients with rheumatoid arthritis. Rev Rhum Engl Ed. 1998; 65(6):387-92. View

Krishnan A, Trump D, Johnson C, Feldman D . The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am. 2010; 39(2):401-18, table of contents. PMC: 5788175. DOI: 10.1016/j.ecl.2010.02.011. View

Merlino L, Curtis J, Mikuls T, Cerhan J, Criswell L, Saag K . Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 2004; 50(1):72-7. DOI: 10.1002/art.11434. View

Ritterhouse L, Crowe S, Niewold T, Kamen D, Macwana S, Roberts V . Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis. 2011; 70(9):1569-74. PMC: 3149865. DOI: 10.1136/ard.2010.148494. View

Nielen M, van Schaardenburg D, Lems W, van de Stadt R, de Koning M, Reesink H . Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthritis Rheum. 2006; 54(11):3719-20. DOI: 10.1002/art.22191. View

10.

Lemire J . Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 1995; 53(1-6):599-602. DOI: 10.1016/0960-0760(95)00106-a. View

11.

Looker A, Pfeiffer C, Lacher D, Schleicher R, Picciano M, Yetley E . Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008; 88(6):1519-27. PMC: 2745830. DOI: 10.3945/ajcn.2008.26182. View

12.

Cherniack E, Levis S, Troen B . Hypovitaminosis D: a widespread epidemic. Geriatrics. 2008; 63(4):24-30. View

13.

Perez-Lopez F . Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas. 2007; 58(2):117-37. DOI: 10.1016/j.maturitas.2007.05.002. View

14.

Holick M . High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81(3):353-73. DOI: 10.4065/81.3.353. View

15.

Gannage-Yared M, Tohme A, Halaby G . [Hypovitaminosis D: a major worldwide public health problem]. Presse Med. 2001; 30(13):653-8. View

16.

Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir A, Balbir-Gurman A . Vitamin D level: is it related to disease activity in inflammatory joint disease?. Rheumatol Int. 2009; 31(4):493-9. DOI: 10.1007/s00296-009-1251-6. View

17.

Damanhouri L . Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J. 2009; 30(10):1291-5. View

18.

Vilarrasa N, Vendrell J, Maravall J, Elio I, Solano E, San Jose P . Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?. Endocrine. 2010; 38(2):235-42. DOI: 10.1007/s12020-010-9379-4. View

19.

Mauricio D, Mandrup-Poulsen T, Nerup J . Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes Metab Rev. 1996; 12(1):57-68. DOI: 10.1002/(SICI)1099-0895(199603)12:1<57::AID-DMR155>3.0.CO;2-L. View

20.

Craig S, Yu F, Curtis J, Alarcon G, Conn D, Jonas B . Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol. 2009; 37(2):275-81. PMC: 3133625. DOI: 10.3899/jrheum.090705. View